FDA Approves New Hemophilia Treatment Hympavzi

Novel therapy targets blood-clotting proteins to prevent bleeding episodes. The U.S. Food and Drug Administration (FDA) has approved Hympavzi (marstacimab) as a novel treatment for hemophilia. The drug…

Read More

HHS Announces Funding for HIV Medication Assistance

$1.4 billion allotted to help 560,000 patients afford life-saving drug. The Department of Health and Human Services (HHS) announced over $1.4 billion has been allocated to HIV medication…

Read More

Supreme Court Blocks Title IX Changes

The administration cannot enforce updates to Title IX rule while the case brought by the states is litigated. The U.S. Supreme Court rejected the request from President Biden’s…

Read More

FDA Authorizes Rapid Point-of-Care Hepatitis C Test

The new testing enables immediate diagnosis and treatment. The U.S. Food and Drug Administration (FDA) granted marketing authorization to Cepheid for the first hepatitis C virus (HCV) test…

Read More

District Judge Rules Against Marijuana Legality in Massachusetts

He says marijuana companies have grounds to sue if taken to the Supreme Court. District Judge Mark Mastroianni rejected the arguments made by Massachusetts marijuana companies, declaring that…

Read More

FDA Panel Votes Against First Proposed MDMA-Based Drug

Available data did not show a benefit to the PTSD patients for which it was intended. This week, a Food and Drug Administration (FDA) advisory panel voted against…

Read More

USAF Updates Mental Health Rules

New policy intended to expedite the treatment of airmen and prioritize their well-being. The U.S. Air Force has revised its mental health protocols, allowing airmen to pursue treatment…

Read More

FDA Approves Gene Therapy for Muscular Dystrophy in Children

Treatment is intended for kids with a confirmed mutation of the DMD gene. The U.S. Food and Drug Administration (FDA) recently approved Elevidys, the first gene therapy for…

Read More

FDA Rejects Antidepressant as COVID Treatment

Request for approval submitted by University of Minnesota professor. The Food and Drug Administration (FDA) published a document last week that declined the emergency use authorization of the…

Read More

FDA Limits Monoclonal Antibody Therapy

White House dismisses as ineffective treatment against COVID-19. The FDA announced on Monday that it would be limiting the use of monoclonal antibody therapies in treating COVID-19. They…

Read More

Back to top
FE3